Jefferies Upgrades Azelis & IMCD: Positive Specialty Chemicals Outlook
Jefferies upgrades Azelis and IMCD to 'buy' amid recovery in organic revenue and strategic updates from new CEOs.
- Latest
- Trending
Jefferies upgrades Azelis and IMCD to 'buy' amid recovery in organic revenue and strategic updates from new CEOs.
Illumina defeats EU in court, curbing merger scrutiny and blocking a $432M fine over Grail acquisition.
Despite bullish sentiment in US stocks, Nasdaq shows risks with 79% long positions in loss, warns Citi's latest analysis.
AI in drug discovery market to skyrocket, reaching USD 11,874.24 million by 2032, with a CAGR of 37.5%.
China outspends South Korea, Taiwan, and the U.S. in chipmaking, aiming for $50B in 2024 to secure stable semiconductor supply.
The dollar dips after hitting two-week highs as investors await crucial U.S. job data influencing Fed rate decisions.
RansomHub ransomware targets 210 victims, exploiting security flaws across key sectors. Learn about their double extortion tactics.
Blackstone buys 80% stake in Burstone's €1.1B logistics fund, boosting expansion.
Candriam introduces a fund offering stable returns, investing in sustainable leaders and shorting less sustainable firms.
Allego's Plug & Charge tech, set for Q4 2024, simplifies EV charging with automatic authentication and payment in Europe.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.